NCT00645255View on ClinicalTrials.gov

Study to Examine the Longer-Term Efficacy and Safety of Sibutramine Hydrochloride in Obese Subjects

PHASE3TerminatedINTERVENTIONAL
Enrollment

466

Participants

Timeline

Start Date

September 30, 1998

Primary Completion Date

January 31, 2003

Conditions
ObesityWeight Loss
Interventions
DRUG

placebo

placebo one capsule daily

DRUG

sibutramine or placebo

one capsule daily

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY

NCT00645255 - Study to Examine the Longer-Term Efficacy and Safety of Sibutramine Hydrochloride in Obese Subjects | Biotech Hunter | Biotech Hunter